Molecular Oncology

The ARUP Molecular Oncology Laboratory offers a broad menu of testing and consultative services in oncology. Testing is designed to aid the physician in answering important clinical questions in the areas of screening, prognosis, treatment, and monitoring. An active research program in the ARUP Institute for Clinical and Experimental Pathology® is committed to developing molecular technologies that will ensure continued quality of clinical testing in the rapidly progressing field of molecular pathology.
Test # Test Name Test Keywords Additional Information
2008604 1p/19q Deletion by FISH 1p19q, Oncology, Paraffin, Brain Tumors, Tumor Additional Technical Information
2007228 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations 5-FU, 5-Fluorouracil Toxicity and Chemotherapeutic Response Panel, Pharmacogenetics (PGx), Colorectal Cancer
2002647 Acute Lymphocytic Leukemia (ALL) Panel by FISH, Adult FISH A ALL, B-Cell Lymphoma, MYC BCR-ABL1, MLL, IGH@, TCF3, E2A
2002719 Acute Lymphocytic Leukemia (ALL) Panel by FISH, Pediatric FISH P ALL, Oncology, Bone Marrow , B-Cell Lymphoma, childhood, child, children, CEP4, CEP10, BCR-ABL1 MLL, ETV6-RUNX1, TEL-AML1
2002653 Acute Myelogenous Leukemia (AML) with Myelodysplastic Syndrome (MDS), or Therapy-Related AML, by FISH F TAML MDS, Myelodysplastic syndrome, Acute Myeloid Leukemia, EGR1, D7S486, MLL
2011132 Acute Myelogenous Leukemia Panel by FISH FISH AML P, Acute Myeloid Leukemia, AML, Myeloproliferative, MPD, PML-RARA, RUNX1T1-RUNX1, ETO-AML1, CBFB, MLL, RPN1/MECOM, EVI1, EGR1, D7S486, KMT2A
2012710 Aggressive B-Cell Lymphoma FISH Reflex, Tissue
2011431 ALK (D5F3) by Immunohistochemistry with Reflex to ALK Gene Rearrangements by FISH
2007324 ALK (D5F3) with Interpretation by Immunohistochemistry ALKD5F3 IP Additional Technical Information
2006102 ALK Gene Rearrangements in NSCLC for Crizotinib Eligibility by FISH ALK GENE, Lung cancer, pharmcogenetics, pulmonary cancer
2006193 B-Cell Clonality Screening (IgH and IgK) by PCR B-Cell Lymphomas, B-cell Leukemias Additional Technical Information
2008420 BCR-ABL1 Mutation Analysis by Next Generation Sequencing Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Tumor Markers, NGS Additional Technical Information
2005017 BCR-ABL1, Major (p210), Quantitative Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)
2005016 BCR-ABL1, Minor (p190), Quantitative Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)
2005010 BCR-ABL1, Qualitative with Reflex to BCR-ABL1 Quantitative Chronic Myelogenous Leukemia (CML)
2007130 Bone Marrow, Chromosome Analysis with Reflex to Genomic Microarray ALL, Bcell, B-cell, b cell, T-cell, Tcell, T Cell, B-ALL, CDKN2A/B, BTG1, IKZF1, EBF1, UPD 9p, Myelodysplastic, MDS, Myeloproliferative, MPD, 5q-; -7 or 7q-,+8; 20q-, LOH, UPD 7q, UPD 11q, UPD 17p, CLL, P53, Chronic lymphocytic leukemia
2002498 BRAF codon 600 Mutation Detection by Pyrosequencing Melanoma, Colorectal cancer, Lynch Syndrome, HNPCC, Hereditary Nonpolyposis Colorectal Cancer, Gastrointestinal Adenocarcinoma, Papillary thyroid carcinoma
0051750 BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation BRAF RFLX, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, Lynch Syndrome, Tumor Markers
2013921 BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
2007132 BRAF V600E Mutation Detection in Hairy Cell Leukemia by Real-Time PCR, Quantitative Additional Technical Information
2012026 Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes BOCAPAN, Breast Cancer, Tumor Markers, FISH, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MEN1, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
2011954 Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing BRCA FGS, BRACA, HBOC
2011949 Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication BRCA FGA, BRACA, HBOC
2010673 CALR (Calreticulin) Exon 9 Mutation Analysis by PCR
2011114 CBFB-MYH11 inv(16) Detection, Quantitative Acute Myeloid Leukemia (AML), Tumor Markers Additional Technical Information
2004247 CEBPA Mutation Detection Acute Myelogenous Leukemia (AML) Additional Technical Information
2002295 Chromosome FISH, CLL Panel FISH CLLP, Chronic Lymphocytic Leukemia, CLL, Lymphoma Phenotyping, B-Cell Lymphomas, Tumor Markers, ATM, D12Z3, D13S319, TP53, p53
2002298 Chromosome FISH, Interphase Oncology, Bone Marrow, Ewing Sarcoma, Neuroblastoma, Myelodysplastic, MDS, Chronic Lymphocytic Leukemia (CLL), Sarcoma, Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Tumor Markers, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Plasma Cell Dyscrasias, Lymphoma Phenotyping, B-Cell Lymphomas Please specify which FISH probe you wish to order.
2011616 Colon Cancer Gene Panel, Somatic
2012769 Cytochrome P450 2C19, CYP2C19 - 9 Variants CYP2C19, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers
2012766 Cytochrome P450 2C9, CYP2C9 - 2 Variants CYP2C9, Warfarin Sensitivity, Pharmacogenetics (PGx) Additional Technical Information
0051232 Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication CYP 2D6, Tamoxifen, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers
2010229 Cytogenomic Molecular Inversion Probe Array, Copy Number and Heterozygosity Assessment - Formalin-Fixed Paraffin-Embedded (FFPE) Tissue FFPE ARRAY, array CGH; aCGH; Array Comparative Genomic Hybridization; Chromosomal Microarray; CMA;  CGH; Microarray; Single-nucleotide-polymorphism (SNP) array; Whole Genome Array; tumor; oncology, formalin-fixed, paraffin-embedded, FFPE; tissue
2006325 Cytogenomic SNP Microarray—Oncology CMA ONC ALL, Bcell, B-cell, b cell, T-cell, Tcell, T Cell, B-ALL, CDKN2A/B, BTG1, IKZF1, EBF1, UPD 9p, Myelodysplastic, MDS, Myeloproliferative, MPD, 5q-; -7 or 7q-,+8; 20q-, LOH, UPD 7q, UPD 11q, UPD 17p, CLL, P53, Chronic lymphocytic leukemia Additional Technical Information
2007223 DDIT3 (CHOP) (12q13) Gene Rearrangement by FISH CHOPFISH, Sarcoma, myxoid liposarcoma, round cell liposarcoma Additional Technical Information
2012166 Dihydropyrimidine Dehydrogenase (DPYD) Genotyping, 3 Mutations DYPD 5-Fluorouracil toxicity 5-FU toxicity 5-FU toxicity 5FU toxicity Adrucil (DPYD) Genotyping, 3 Mutations Xeloda (capecitabine) (DPYD) Genotyping, 3 Mutations DPD Uftoral (tegafur/uracil) (DPYD) Genotyping, 3 Mutations
0095155 DNA Content/Cell Cycle Analysis, Miscellaneous
2008605 EGFR by FISH EGFRFISH, Head and Neck Cancer, Lung Cancer, Brain Tumors Additional Technical Information
2002440 EGFR Mutation Detection by Pyrosequencing Lung Cancer Additional Technical Information
2010696 EIF2AK4-Associated Disorders (EIF2AK4) Sequencing
2002378 Eosinophilia Panel by FISH FISH EOS P, Mast Cell Disease, Eosinophilic Diseases, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), PDGFRA-CHIC2-FIP1L1, PDGFRB, FGFR1, CBFB
2013906 Epi proColon
2007914 EPOR Mutation Detection by Sequencing Additional Technical Information
2002902 Epstein-Barr Virus (EBV) by in situ Hybridization, Paraffin Epstein-Barr Virus (EBV), Nasopharyngeal carcinoma, NK/ T-cell lymphomas, B-cell lymphomas, Post transplant lymphoproliferative disorders, Tumor Markers, ISH, Nasopharyngeal nonkeratinizing undifferentiated carcinoma, Nasal type NK/T-cell lymphoma
2008603 ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue HER2FISH, Breast Cancer, Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu, pathvision, pathvysion
2007332 ERBB2 (HER2)(HercepTest) by Immunohistochemistry HERCEP IHC
0049178 ERBB2 (HercepTest®) by Immunohistochemistry, Tissue with Reflex to FISH if 2+ Gastric, gastrointestinal cancer, tumor marker, pharmacogenetics, Breast Cancer, Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu, Pancreatic Cancer, Gastric Cancer, Barrett’s Esophagus Cancer, Gastroesophageal Junction Cancer
0049174 ERBB2 (HercepTest®) with Interpretation by Immunohistochemistry, Tissue Gastric, gastrointestinal cancer, tumor marker, pharmacogenetics, Breast Cancer, Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu, Pancreatic Cancer, Gastric Cancer, Barrett’s Esophagus Cancer, Gastroesophageal Junction Cancer
2007225 EWSR1 (22q12) Gene Rearrangement by FISH EWSR1, Ewing Sarcoma, Sarcoma, Tumor Markers Additional Technical Information
2004863 Familial Adenomatous Polyposis (APC) Sequencing APC FGS, Colorectal Cancer, colon cancer, CRC, polyps, Familial Adenomatious Polyposis FAP, familial cancer
2004915 Familial Adenomatous Polyposis Panel: APC Sequencing, APC Deletion/Duplication, and MYH 2 Mutations FAP Panel, Familial Adenomatious Polyposis familial cancer, Colorectal Cancer, colon cancer, CRC, polyps, FAP, familial cancer
2001961 Familial Mutation, Targeted Sequencing SEQ FSM

The following genes are available:
ACADVL, ACADM, ACVRL1, APC, ASS1, ATP7A, BMPR1A, BMPR2, BTD, CCM1, CCM2, CCM3, CDKL5, CFTR, COL4A5, CYP1B1, ENG, F8, F9, FBN1, G6PD, GALT, GJB2; HBA1, HBA2, HBB, INSR, LMNA, MECP2,MEFV, MEN1, MLH1, MSH2; MSH6, MUTYH, MYH3, NF1, OTC, PLOD1, PMS2; PRSS1, PTEN, PTPN11, RASA1, RET, SDHB, SDHC, SDHD, SLC22A5, SLC25A13, SMAD4, SPRED1, SPINK1, SOS1, STK11, TACI, TGFBR1, TGFBR2, UBE3A, VHL, VWF

2001497 FOXO1 (FKHR) (13q14) Gene Rearrangement by FISH FKHRFISH, Sarcoma, FOX, FOXO1, 13q14, alveolar rhabdomyosarcoma Additional Technical Information
2002674 Gastrointestinal Stromal Tumor Mutation Gastrointestinal Stromal Tumors (GIST) Additional Technical Information
2007108 Hereditary Paraganglioma-Pheochromocytoma (SDHB) Sequencing and Deletion/Duplication Additional Technical Information
2007113 Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Deletion/Duplication Additional Technical Information
2007167 Hereditary Paraganglioma-Pheochromocytoma (SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication Panel
2007117 Hereditary Paraganglioma-Pheochromocytoma (SDHC) Sequencing and Deletion/Duplication Additional Technical Information
2007122 Hereditary Paraganglioma-Pheochromocytoma (SDHD) Sequencing and Deletion/Duplication Additional Technical Information
0051650 HNPCC/Lynch Syndrome (MLH1) Sequencing and Deletion/Duplication MLH1 FGA, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, MLH1, MSH2, MSH6, PMS2, mismatch repair, Muir-Torre, Turcot, Lynch
0051654 HNPCC/Lynch Syndrome (MSH2) Sequencing and Deletion/Duplication MSH2 FGA, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, MLH1, MSH2, MSH6, PMS2, mismatch repair, Muir-Torre, Turcot, Lynch Additional Technical Information
0051656 HNPCC/Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication MSH6 FGA, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, MLH1, MSH2, MSH6, PMS2, mismatch repair, Muir-Torre, Turcot, Lynch Additional Technical Information
0051737 HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication PMS2 FGA, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, MLH1, MSH2, MSH6, PMS2, mismatch repair, Muir-Torre, Turcot, Lynch Additional Technical Information
2001728 HNPCC/Lynch Syndrome Deletion/Duplication HNPCC DD, Hereditary Nonpolyposis Colorectal Cancer, Colorectal Cancer, MLH1, MSH2, MSH6, PMS2, mismatch repair, Muir-Torre, Turcot, Lynch Syndrome Additional Technical Information
2012175 HRAS Mutation Detection by Pyrosequencing
0065999 Human Papillomavirus (HPV) DNA Probe, High Risk, Cervical Brush Gynecologic Cancer
2007894 Human Papillomavirus (HPV) Genotypes 16 and 18/45, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
2002899 Human Papillomavirus (HPV) High Risk In Situ Hybridization, Paraffin Gynecologic Cancer, ISH
0060744 Human Papillomavirus (HPV), High Risk by Hybrid Capture (SurePath) Human Papillomavirus (HPV), Cervical Cancer, Tumor Markers
2008404 Human Papillomavirus (HPV), High Risk by Hybrid Capture, ThinPrep Human Papillomavirus (HPV), Cervical Cancer, Tumor Markers
2007893 Human Papillomavirus (HPV), High Risk, E6/E7 mRNA by Transcription-Mediated Amplification (TMA)
2006444 IDH1 and IDH2 Mutation Analysis, exon 4 Gliomas, cytogenically normal AML cases Additional Technical Information
2007357 IDH1 R132H Point Mutation with Interpretation by Immunohistochemistry IDH1 IP Additional Technical Information
2001536 IGH-BCL2 Fusion, t(14;18) by FISH for Detection in Follicular Lymphoma B-Cell Lymphomas, Follicular lymphoma, Diffuse large B-cell lymphoma, FISH Additional Technical Information
0055557 IGH-CCND1 (BCL-1/JH) Translocation, t(11;14) by PCR Mantle cell Lymphoma , B-Cell Lymphomas, Tumor Markers Additional Technical Information
2007226 IGH-CCND1 Fusion, t(11;14) by FISH Mantle cell lymphoma, B-Cell Lymphomas, Plasma cell dyscrasias, Tumor Markers Additional Technical Information
2001538 IGH-MYC Fusion t(8;14) by FISH for Detection in Burkitt Lymphoma Burkitt lymphoma, B-Cell Lymphomas Additional Technical Information
0040227 IGHV Mutation Analysis by Sequencing Chronic Lymphocytic Leukemia (CLL), Lymphoma Phenotyping, B-Cell Lymphomas, Tumor Markers Additional Technical Information
2002357 JAK2 Exon 12 Mutation Analysis by PCR Myeloproliferative Neoplasms (MPN), Tumor Markers Additional Technical Information
0051245 JAK2 Gene, V617F Mutation, Qualitative Myeloproliferative Neoplasms (MPN), Tumor Markers Additional Technical Information
2012084 JAK2 Gene, V617F Mutation, Qualitative with Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR with Reflex to MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative
2012085 JAK2 Gene, V617F Mutation, Qualitative with Reflex to JAK2 Exon 12 Mutation Analysis by PCR
0040168 JAK2 Gene, V617F Mutation, Quantitation Myeloproliferative Neoplasms (MPN), Tumor Markers Additional Technical Information
2004988 Juvenile Polyposis (BMPR1A) Sequencing BMPR1A FGS, JPS, SMAD4, Juvenile Polyposis
2004992 Juvenile Polyposis (BMPR1A) Sequencing and Deletion/Duplication BMPR1A FGA, JPS, SMAD4
2001976 Juvenile Polyposis (SMAD4) Deletion/Duplication SMAD4 DD, Hereditary Hemorrhagic Telangiectasia (HHT), JP/HHT, BMPR1A, JPS, Juvenile Polyposis
0051510 Juvenile Polyposis (SMAD4) Sequencing SMAD4 SEQ, Hereditary Hemorrhagic Telangiectasia (HHT), JP/HHT, BMPR1A, JPS, Myhre, Juvenile Polyposis
2001971 Juvenile Polyposis (SMAD4) Sequencing and Deletion/Duplication SMAD4 FGA, Hereditary Hemorrhagic Telangiectasia (HHT), JP/HHT, BMPR1A, JPS, Juvenile Polyposis
2004984 Juvenile Polyposis Syndrome (BMPR1A) Deletion/Duplication BMPR1A DD, JPS, SMAD4, Juvenile Polyposis
0040137 KIT (D816V) Mutation by PCR Mast Cell Disease, C-KIT, CKIT Additional Technical Information
2002437 KIT Mutations in AML by Fragment Analysis and Sequencing Acute Myeloid Leukemia (AML), C-KIT, CKIT Additional Technical Information
2002695 KIT Mutations, Melanoma Melanoma, Tumor Markers, C-KIT, CKIT Additional Technical Information
2001932 KRAS Mutation Detection with BRAF reflex Pharmacogenetics (PGx), Lung Cancer, Colorectal Cancer, Tumor Markers, CRC, colon, rectal Additional Technical Information
2007131 Leukemic Blood, Chromosome Analysis with Reflex to Genomic Microarray
2008894 Lung Cancer Panel Panel consist of EFGR, ALK, ROS1, if ROS1 equivocal reflex to ROS1 FISH
Additional Technical Information
2008895 Lung Cancer Panel with KRAS Panel consist of EFGR, KRAS, ALK, ROS1, if ROS1 equivocal reflex to ROS1 FISH
Additional Technical Information
2002650 Lymphoma (Aggressive) Panel by FISH FISH ALYMP, Lymphoma Phenotyping, B-Cell Lymphomas, Lymphoproliferative Disorders (LPD), BCL6, MYC, IGH@/BCL2 Additional Technical Information
2003016 MDM2 Gene Amplification by FISH MDM2 FISH, Sarcoma, Tumor Markers, MDM2, Murine Double Minute 2 Additional Technical Information
0055655 Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations MTHFR PCR, Thrombophilia, methotrexate sensitivity, cardiovascular, C677T, A1298C
2009310 MGMT Methylation Detection by PCR
0051740 Microsatellite Instability (MSI), HNPCC/Lynch Syndrome, by PCR MSI PCR, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, Lynch Syndrome, Tumor Markers, MSI, MLH1, MSH2, MSH6, PMS2, mismatch repair Additional Technical Information
0049302 Mismatch Repair by Immunohistochemistry MSI, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, Tumor Markers, MLH1, MSH2, MSH6, PMS2, mismatch repair, IHC, Lynch Additional Technical Information
2002327 Mismatch Repair by Immunohistochemistry with Reflex to BRAF Codon 600 Mutation and MLH1 Promoter Methylation Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, Tumor Markers, MSI, MLH1, MSH2, MSH6, PMS2, mismatch repair, IHC, Lynch
2005270 Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation MSI MLH1, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Colorectal Cancer, Tumor Markers, MLH1, MSH2, MSH6, PMS2, mismatch repair, IHC, Lynch Additional Technical Information
2002499 MLH1 Promoter Methylation, Paraffin MLH1PCR, Colorectal Cancer, Hereditary Nonpolyposis Colorectal Cancer, HNPCC, Tumor Markers Additional Technical Information
2005545 MPL codon 515 Mutation Detection by Pyrosequencing, Quantitative Myeloproliferative Neoplasms, MPN Additional Technical Information
2005346 Multiple Endocrine Neoplasia Type 1 (MEN1) Deletion/Duplication Multiple endocrine adenomatosis, Wermer, Multiple Endocrine Neoplasias (MEN)
2005359 Multiple Endocrine Neoplasia Type 1 (MEN1) Sequencing MEN1 FGS, Multiple endocrine adenomatosis, Wermer syndrome, Multiple Endocrine Neoplasias (MEN)
2005360 Multiple Endocrine Neoplasia Type 1 (MEN1) Sequencing and Deletion/Duplication MEN1 FGA, Multiple endocrine adenomatosis, Wermer syndrome, Multiple Endocrine Neoplasias (MEN)
0051390 Multiple Endocrine Neoplasia Type 2 (MEN2), RET Gene Mutations by Sequencing MEN2 SEQ, Thyroid Cancer, Pheochromocytoma, Multiple Endocrine Neoplasias (MEN), MEN 2A, MEN 2B, familial medullary thyroid carcinoma, FMTC, RET proto-oncogene
2002294 Multiple Myeloma Panel by FISH FISH MMP, Plasma Cell Dyscrasias, CKS1B, ASS1, CCND1-IGH@, IGH@, PML, TP53, FGFR3-IGH@, IGH@-MAF
2004911 MUTYH-Associated Polyposis (MUTYH) 2 Mutations MYH SEQ, Hereditary Colorectal Cancer, MAP, MUTH Associated Polyposis
2002345 MYC (8q24) Gene Rearrangement by FISH Burkitt lymphomas, B-Cell Lymphomas, Double Hit lymphomas, Tumor Markers Additional Technical Information
2007227 MYCN (N-MYC) Gene Amplification by FISH NMYC, Neuroblastoma, Tumor Markers Additional Technical Information
2009318 MYD88 L265P Mutation Detection by PCR, Quantitative Additional Technical Information
2002709 Myelodysplastic Syndrome (MDS) Panel by FISH FISH MDS P, Myelodysplastic Syndrome (MDS), EGR1, D7S486, CEP8, D20S108
2011117 Myeloid Malignancies Mutation Panel by Next Generation Sequencing Additional Technical Information
2012182 Myeloid Malignancies Somatic Mutation and Copy Number Analysis Panel MYE CMANGS same as CMA ONC, MYE NGS
2002360 Myeloproliferative Disorders Panel by FISH FISH MPD P, Chronic Myelogenous Leukemia (CML), Myeloproliferative Neoplasms (MPN), PDGFRα-CHIC2-FIP1L1, PDGFRa-CHIC2-FIP1L1, PDGFRβ, FGFR1, ABL1-BCR
0040174 NPM1 Mutation by PCR and Fragment Analysis Acute Myeloid Leukemia (AML) Additional Technical Information
2003123 NRAS Mutation Detection by Pyrosequencing Colorectal, melanoma, Hereditary Nonpolyposis Colorectal Cancer , HNPCC, Tumor Markers, CRC, colon, rectal Additional Technical Information
2012603 PAX8-PPARG Translocations Detection by PCR
2010102 PCA3 - Prostate Cancer Biomarker by Transcription-Mediated Amplification Additional Technical Information
2008377 Peutz-Jeghers Syndrome (STK11) Deletion/Duplication STK11, STK11 DD, hamartomatous polyps, mucocutaneous hypergigmentation
2008394 Peutz-Jeghers Syndrome (STK11) Sequencing STK11, STK11 FGS, hamartomatous polyps, mucocutaneous hypergigmentation
2008398 Peutz-Jeghers Syndrome (STK11) Sequencing and Deletion/Duplication STK11, STK11 FGA, hamartomatous polyps, mucocutaneous hypergigmentation
2004510 PIK3CA Mutation Detection Tumor Markers, Breast Cancer, Colorectal Cancer, Lung Cancer, Gastrointestinal Cancer, Pancreatic Cancer Additional Technical Information
2002871 PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative Acute Myelogenous Leukemia (AML), Acute Promyelocytic Leukemia (APL) Additional Technical Information
2002363 PML/RARα Translocation by FISH FISH PML, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), Tumor Markers
2010248 Prosigna Breast Cancer Prognostic Gene Signature pam50, pam 50, PAM50, PAM 50, PAM-50
0080206 Prostate Specific Antigen, Free Percentage (includes Free PSA and Total PSA), Serum or Plasma Genitourinary Cancer, Prostate cancer, tumor marker
0070121 Prostate Specific Antigen, Total, Serum or Plasma Genitourinary Cancer, Prostate cancer, tumor marker
2012654 RET Gene Rearrangements by FISH
2012605 RET-CCDC6 and RET-NCOA4 (RET-PTC1 and RET-PTC3) Translocations Detection by PCR
2008414 ROS1 with Interpretation by Immunohistochemistry with Reflex to FISH if Equivocal Additional Technical Information
2010138 RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Detection, Quantitative
2006948 SDHB with Interpretation by Immunohistochemistry
2007991 Solid Tumor Mutation Panel by Next Generation Sequencing Additional Technical Information
2007222 SS18 (SYT) (18q11) Gene Rearrangement by FISH Additional Technical Information
2008409 T-Cell Clonality by Next Generation Sequencing Additional Technical Information
0055567 T-Cell Clonality Screening by PCR Hematologic Cancer, Sézary Syndrome, T-Cell Lymphomas, Lymphoma Phenotyping
2012233 Thiopurine Methyltransferase (TPMT) Genotyping, 4 Variants TPMT DNA 6-mercaptopurine 6-MP 6MP toxicity 6-thioguanine 6-TG 6TG AZA toxicity Azathioprine S-adenosyl-L-methionine genotype Thioguanine Thiopurine S-Methyltransferase genotype Thiopurine TPMT mutation TPMT gene TPMT genetics Additional Technical Information
0092066 Thiopurine Methyltransferase, RBC TPMT RBC, Thiopurine Methyltransferase Activity (TPMT), Pharmacogenetics (PGx), Immunosuppressive Drugs, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) Additional Technical Information
2012755 Thyroid Translocation and Mutation Panel
0051332 UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping UGT1A1, Irinotecan, Pharmacogenetics (PGx), Colorectal Cancer
2001181 UroVysion FISH UF, Bladder Cancer, Tumor Markers, urine
2005766 WT1 Mutation Detection by Sequencing AML Additional Technical Information
0092392 ZAP-70 Analysis by Flow Cytometry Chronic Lymphocytic Leukemia (CLL), Lymphoma Phenotyping, B-Cell Lymphomas, Tumor Markers Additional Technical Information